Cargando…
Specific Pharmacological Effects of Paroxetine Comprise Psychological but Not Somatic Symptoms of Depression
BACKGROUND: Meta-analyses of placebo-controlled trials of SSRIs suggest that only a small portion of the observable change in depression may be attributed to "true" pharmacological effects. But depression is a multidimensional construct, so treatment effects may differ by symptom cluster....
Autores principales: | Schalet, Benjamin D., Tang, Tony Z., DeRubeis, Robert J., Hollon, Steven D., Amsterdam, Jay D., Shelton, Richard C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4954666/ https://www.ncbi.nlm.nih.gov/pubmed/27438078 http://dx.doi.org/10.1371/journal.pone.0159647 |
Ejemplares similares
-
Cross-sectional networks of depressive symptoms before and after antidepressant medication treatment
por: Bos, Fionneke M., et al.
Publicado: (2018) -
The importance of transdiagnostic symptom level assessment to understanding prognosis for depressed adults: analysis of data from six randomised control trials
por: O’Driscoll, C., et al.
Publicado: (2021) -
Predicting prognosis for adults with depression using individual symptom data: a comparison of modelling approaches
por: Buckman, J. E. J., et al.
Publicado: (2023) -
What factors indicate prognosis for adults with depression in primary care? A protocol for meta-analyses of individual patient data using the Dep-GP database
por: Buckman, Joshua E.J., et al.
Publicado: (2020) -
Decision-Making and Depressive Symptomatology
por: Leykin, Yan, et al.
Publicado: (2010)